Stockreport

Beam Therapeutics GAAP EPS of -$1.17 misses by $0.02, revenue of $14.27M beats by $0.14M [Seeking Alpha]

Beam Therapeutics Inc.  (BEAM) 
PDF Cash Position: Cash, cash equivalents and marketable securities were $925.8 million as of September 30, 2024, compared to $1.2 billion as of December 31, 2023. More o [Read more]